J Parkinsons Dis 7:289299 Sechi G, Deledda MG, Bua G, Satta WM, Deiana GA, Pes GM, Rosati G (1996) Reduced intravenous glutathione in the treatment of early Parkinson's disease
Lycium barbarum polysaccharide counteracts this hepatotoxicity by preserving mitochondrial integrity and activating Nrf2 signaling, supporting its potential as a protective agent against cadmium-induced liver damage (126)
J Cell Commun Signal
The landmark PANTHEON trial, a 1-year multicenter RCT in 1,006 Chinese COPD patients, found that high-dose NAC (600 mg twice daily) reduced the rate of acute exacerbations by 22% compared to placebo (1.16 vs 1.49 exacerbations per year, p=0.0011) (Zheng et al., Lancet Respir Med, 2014) [44]
P =0.001) [66]
Remember, the retina's a sports car, it burns out